Matches in SemOpenAlex for { <https://semopenalex.org/work/W90450827> ?p ?o ?g. }
Showing items 1 to 66 of
66
with 100 items per page.
- W90450827 endingPage "72" @default.
- W90450827 startingPage "1968" @default.
- W90450827 abstract "Controversial results are present in clinical studies on the effect of octreotide in the treatment of patients with acute pancreatitis. The aim of this study was to analyze the effect of octreotide in biochemical, physiological and radiological prognostic criteria of acute pancreatitis at the end of 48 hours.Between January 1995 and August 1997, we conducted a prospective controlled clinical study. Forty-three patients with a diagnosis of acute pancreatitis (acute abdominal pain and a serum amylase >1000 IU/liter) were sequentially allocated to treatment with high dose octreotide (N=22), 0.5 microg/kg/hr by continued i.v. infusion, or designated as controls (N=21). The other aspects of the treatment protocol were similar in both groups.There was no significant difference between the two groups on admission with regard to Ranson criteria (P=0.13). A significant difference was not observed in fasting blood glucose, albumin, calcium, hemoglobin, hematocrit, white blood cell count, LDH, AST, urea, systolic and diastolic pressure, heart rate and pyrexial changes between the two groups at admission and at the end of 48 hours (p>0.05), but serum amylase changes were significantly different (p=0.000). Pleural effusion at the end of 48 hours was more frequent in the octreotide treated group (22.7% vs. 9.5%, p>0.05), but pancreatic edema (52.4% vs. 13.6%, p=0.022), ascites (19.5% vs. 4.5%, p>0.05) and retroperitoneal edema (4.76% vs. 4.5%, p>0.05) were observed more frequently in the control group. One death occurred in each group. Patients treated with octreotide tolerated oral intake sooner than the control group (3.76 vs. 4.9 days, p=0.041).Although biochemical and physiologic changes between the two groups were not significantly different, a more pronounced decrease in serum amylase levels, improvements in pancreatic edema and earlier return to oral intake in the high dose-octreotide group suggest that octreotide may have a beneficial role in the management of acute pancreatitis." @default.
- W90450827 created "2016-06-24" @default.
- W90450827 creator A5018173620 @default.
- W90450827 creator A5046103057 @default.
- W90450827 creator A5050868628 @default.
- W90450827 creator A5081845624 @default.
- W90450827 date "1999-08-03" @default.
- W90450827 modified "2023-09-27" @default.
- W90450827 title "High dose octreotide in the management of acute pancreatitis." @default.
- W90450827 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/10430379" @default.
- W90450827 hasPublicationYear "1999" @default.
- W90450827 type Work @default.
- W90450827 sameAs 90450827 @default.
- W90450827 citedByCount "12" @default.
- W90450827 countsByYear W904508272013 @default.
- W90450827 countsByYear W904508272014 @default.
- W90450827 countsByYear W904508272015 @default.
- W90450827 countsByYear W904508272017 @default.
- W90450827 crossrefType "journal-article" @default.
- W90450827 hasAuthorship W90450827A5018173620 @default.
- W90450827 hasAuthorship W90450827A5046103057 @default.
- W90450827 hasAuthorship W90450827A5050868628 @default.
- W90450827 hasAuthorship W90450827A5081845624 @default.
- W90450827 hasConcept C126322002 @default.
- W90450827 hasConcept C2775967933 @default.
- W90450827 hasConcept C2776297358 @default.
- W90450827 hasConcept C2776670229 @default.
- W90450827 hasConcept C2779634585 @default.
- W90450827 hasConcept C2780496750 @default.
- W90450827 hasConcept C2780955771 @default.
- W90450827 hasConcept C2780959883 @default.
- W90450827 hasConcept C2781025020 @default.
- W90450827 hasConcept C71924100 @default.
- W90450827 hasConcept C90924648 @default.
- W90450827 hasConceptScore W90450827C126322002 @default.
- W90450827 hasConceptScore W90450827C2775967933 @default.
- W90450827 hasConceptScore W90450827C2776297358 @default.
- W90450827 hasConceptScore W90450827C2776670229 @default.
- W90450827 hasConceptScore W90450827C2779634585 @default.
- W90450827 hasConceptScore W90450827C2780496750 @default.
- W90450827 hasConceptScore W90450827C2780955771 @default.
- W90450827 hasConceptScore W90450827C2780959883 @default.
- W90450827 hasConceptScore W90450827C2781025020 @default.
- W90450827 hasConceptScore W90450827C71924100 @default.
- W90450827 hasConceptScore W90450827C90924648 @default.
- W90450827 hasIssue "27" @default.
- W90450827 hasLocation W904508271 @default.
- W90450827 hasOpenAccess W90450827 @default.
- W90450827 hasPrimaryLocation W904508271 @default.
- W90450827 hasRelatedWork W2009544312 @default.
- W90450827 hasRelatedWork W2235039055 @default.
- W90450827 hasRelatedWork W2268892304 @default.
- W90450827 hasRelatedWork W2391327900 @default.
- W90450827 hasRelatedWork W2405007109 @default.
- W90450827 hasRelatedWork W2751085238 @default.
- W90450827 hasRelatedWork W2774910939 @default.
- W90450827 hasRelatedWork W2945807451 @default.
- W90450827 hasRelatedWork W3029438502 @default.
- W90450827 hasRelatedWork W90450827 @default.
- W90450827 hasVolume "46" @default.
- W90450827 isParatext "false" @default.
- W90450827 isRetracted "false" @default.
- W90450827 magId "90450827" @default.
- W90450827 workType "article" @default.